Press release
Hereditary Angioedema Therapeutics - Pipeline Analysis, Clinical Trials and Key Players Shire, BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc.
HAE is a disease characterized by repeated incidents of swelling (angioedema). Some of the common body areas that get affected due to this disease include intestinal tract, face, limbs, and airway. The stress can cause a heart attack, but most often in the patients suffering from HAE, the swelling occurs with an unknown trigger.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/hereditary-angioedema-therapeutics-pipeline-analysis/report-sample
*Positive Clinical Results of HAE Therapeutics Candidates
The positive clinical results of HAE drug candidates are driving the pipeline growth. For instance, Attune Pharmaceuticals, Inc., announced the Pre-Clinical data results for ATN-249, a novel orally administered plasma kallikrein inhibitor for the treatment of HAE. Studies demonstrated that ATN-249 was highly selective and potent at plasma kallikrein inhibition in both biochemical inhibition and contact activation assays. Therefore, the positive clinical results of the compounds under the development for the treatment of HAE, are fueling the research and development investment being made by the players developing drugs for the treatment of HAE.
Browse report at: https://www.psmarketresearch.com/market-analysis/hereditary-angioedema-therapeutics-pipeline-analysis
Some of the key players developing drugs for the treatment of HAE therapeutics include Shire plc, BioCryst Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc.
*Technological Advancements for Drug Development to Boost the HAE Pipeline Growth
Most of the companies have developed novel technologies for the development of drug candidates for the treatment of HAE. For instance, Arrowhead Pharmaceuticals, Inc. has established a drug discovery, and development platform that has broad licenses to fundamental intellectual property and extensive scientific expertise after more than a decade working on RNAi-based therapies. These technologically advanced platforms enable the players in the pipeline to develop effective new therapies rapidly, that are cost effective and potentially have lower risk, relative to traditional approaches. These technological advancements act as a key driver for pipeline growth.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Angioedema Therapeutics - Pipeline Analysis, Clinical Trials and Key Players Shire, BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc. here
News-ID: 1417242 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for HAE
Global RTU Porcelain Enamel Market Insights, Forecast to 2029-Ferro, Prince, HAE …
The global RTU Porcelain Enamel market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global RTU Porcelain Enamel market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of…
Hereditary Angioedema (HAE) Treatment Market Analysis Report 2022 - 2030
Acumen Research and Consulting has announced the addition of the "Hereditary Angioedema (HAE) Treatment Market" report to their offering.
The Hereditary Angioedema (HAE) Treatment Market Report 2030 is an in depth study analyzing the current state of the Hereditary Angioedema (HAE) Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Hereditary Angioedema (HAE) Treatment Market provides analysis…
HAE MEMBERSHIP GIVES DIAMOND BLADES BUSINESS A CUTTING EDGE
The UK construction industry brings in billions of pounds of new work every month*. The sector relies on tool and equipment hire companies to deliver the kit needed to undertake these projects, so how can suppliers gain a competitive edge in such an important marketplace?
Established in 2003, Mexco has already grown from its Cornwall base to become one of the UK and Ireland’s largest privately-owned suppliers of diamond blades, core…
MENTAL HEALTH IN THE SPOTLIGHT AT HAE EHA CONFERENCE
Members, non-members and exhibitors attending HAE EHA’s annual conference at Holywell Park in Loughborough were given an ideal opportunity to assess and improve their strategies for dealing with mental health in the workplace by expert speakers on this growing issue.
It is estimated mental health problems blight one in four of the UK population (http://www.hse.gov.uk/stress/mental-health.htm), a figure replicated last year in the construction industry according to a survey by Construction News’…
Hereditary Angioedema (HAE) - Pipeline Review, Trends, and Forecast Report 2017
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Hereditary Angioedema (HAE) - Pipeline Review, H1 2017” to its report offerings. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1196650
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) -…
Hereditary Angioedema (HAE) Market Research Report | Forecast up to 2024
Global Hereditary Angioedema (HAE) Market: Overview
Hereditary angioedema (HAE) is a rare inherited disease, which leads to repeated episodes of swelling beneath the surface of the skin. Hereditary angioedema is confined to the face, tongue, feet, legs, hands and arms. However, it sometimes leads to swelling in airways such as trachea, larynx or intestinal tract may prove out to be fatal.
For the treatment of hereditary angioedema, currently there are no medications…
